On December 7, US drugmaker Moderna said it was applying for emergency use authorisation for its COVID-19 vaccine. A few days earlier, Pfizer applied for emergency use authorisation for the vaccine it has developed in collaboration with BioNTech. In India, Serum Institute of India, which is trialling a version of the AstraZeneca-Oxford vaccine, has said it expects to seek emergency use authorisation within the next two weeks. Watch the video to know what is emergency use authorisation (EUA) and more.
Google Trends